Suppr超能文献

食欲调节:激素、肽类和神经递质及其在肥胖中的作用

Appetite Regulation: Hormones, Peptides, and Neurotransmitters and Their Role in Obesity.

作者信息

Miller Gary D

机构信息

Department of Health and Exercise Science, Wake Forest University, Winston-Salem, North Carolina.

出版信息

Am J Lifestyle Med. 2017 Jun 23;13(6):586-601. doi: 10.1177/1559827617716376. eCollection 2019 Nov-Dec.

Abstract

Understanding body weight regulation will aid in the development of new strategies to combat obesity. This review examines energy homeostasis and food intake behaviors, specifically with regards to hormones, peptides, and neurotransmitters in the periphery and central nervous system, and their potential role in obesity. Dysfunction in feeding signals by the brain is a factor in obesity. The hypothalamic (arcuate nucleus) and brainstem (nucleus tractus solitaris) areas integrate behavioral, endocrine, and autonomic responses via afferent and efferent pathways from and to the brainstem and peripheral organs. Neurons present in the arcuate nucleus express pro-opiomelanocortin, Neuropeptide Y, and Agouti Related Peptide, with the former involved in lowering food intake, and the latter two acutely increasing feeding behaviors. Action of peripheral hormones from the gut, pancreas, adipose, and liver are also involved in energy homeostasis. Vagal afferent neurons are also important in regulating energy homeostasis. Peripheral signals respond to the level of stored and currently available fuel. By studying their actions, new agents maybe developed that disable orexigenic responses and enhance anorexigenic signals. Although there are relatively few medications currently available for obesity treatment, a number of agents are in development that work through these pathways.

摘要

了解体重调节将有助于开发对抗肥胖的新策略。本综述探讨能量稳态和食物摄入行为,特别是关于外周和中枢神经系统中的激素、肽和神经递质,以及它们在肥胖中的潜在作用。大脑中进食信号的功能障碍是肥胖的一个因素。下丘脑(弓状核)和脑干(孤束核)区域通过来自脑干和外周器官的传入和传出通路整合行为、内分泌和自主反应。弓状核中的神经元表达促黑素细胞皮质激素原、神经肽Y和刺鼠相关肽,前者参与降低食物摄入量,后两者则会急剧增加进食行为。来自肠道、胰腺、脂肪和肝脏的外周激素的作用也参与能量稳态。迷走神经传入神经元在调节能量稳态中也很重要。外周信号对储存的和当前可用的燃料水平做出反应。通过研究它们的作用,可能会开发出能够抑制促食欲反应并增强抑食欲信号的新药物。尽管目前可用于肥胖治疗的药物相对较少,但有许多药物正在通过这些途径进行研发。

相似文献

2
Peptides and food intake.肽与食物摄入。
Front Endocrinol (Lausanne). 2014 Apr 24;5:58. doi: 10.3389/fendo.2014.00058. eCollection 2014.
3
Neuroendocrine control of food intake.食物摄入的神经内分泌控制。
Nutr Metab Cardiovasc Dis. 2008 Feb;18(2):158-68. doi: 10.1016/j.numecd.2007.06.004. Epub 2007 Dec 3.
4
Hypothalamic regulation of appetite.下丘脑对食欲的调节。
Expert Rev Endocrinol Metab. 2008 Sep;3(5):577-592. doi: 10.1586/17446651.3.5.577.
7
Determinants of body weight regulation in humans.人类体重调节的决定因素。
Arch Endocrinol Metab. 2016 Apr;60(2):152-62. doi: 10.1590/2359-3997000000129. Epub 2016 Feb 23.
10
Afferent signals regulating food intake.调节食物摄入的传入信号。
Proc Nutr Soc. 2000 Aug;59(3):373-84. doi: 10.1017/s0029665100000422.

引用本文的文献

4
Obesity and cancer: unravelling the microbiome's hidden role.肥胖与癌症:揭示微生物组的隐藏作用
Front Nutr. 2025 Jun 9;12:1602603. doi: 10.3389/fnut.2025.1602603. eCollection 2025.

本文引用的文献

2
Emerging drugs for the treatment of obesity.治疗肥胖症的新兴药物。
Expert Opin Emerg Drugs. 2017 Mar;22(1):87-99. doi: 10.1080/14728214.2017.1269744. Epub 2016 Dec 16.
3
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.司美格鲁肽与 2 型糖尿病患者的心血管结局
N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15.
6
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.利拉鲁肽与2型糖尿病患者的心血管结局
N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.
8
Neurotrophic factor control of satiety and body weight.神经营养因子对饱腹感和体重的控制。
Nat Rev Neurosci. 2016 May;17(5):282-92. doi: 10.1038/nrn.2016.24. Epub 2016 Apr 7.
9
Management of obesity.肥胖管理。
Lancet. 2016 May 7;387(10031):1947-56. doi: 10.1016/S0140-6736(16)00271-3. Epub 2016 Feb 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验